Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

52.55
Delayed Data
As of Oct 20
 0.00 / 0.00%
Today’s Change
38.30
Today|||52-Week Range
62.95
-2.59%
Year-to-Date
Tributary Capital Management, LLC Buys J. ...
Oct 19 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close52.55
Today’s open52.95
Day’s range52.50 - 53.40
Volume266,944
Average volume (3 months)283,501
Market cap$1.7B
Dividend yield--
Data as of 4:02pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+7.40%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+13.23%
P/E ratio17.9
Price/Sales3.63
Price/Book4.19

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...-0.33-1.01%
CORTCorcept Therapeutics...+0.09+0.49%
ARRYArray Biopharma Inc-0.26-2.29%
RGENRepligen Corp+0.81+2.18%
Data as of 4:14pm ET, 10/20/2017

Financials

Next reporting dateNovember 3, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts